Abstract
MicroRNAs (miRNAs) are small endogenous non-coding RNAs (nc-RNAs) that are involved in many physiological processes. The deregulation of miRNAs can cause a number of diseases, including cancer. The aberrant expression of these master regulators makes them important as therapeutic targets. Some ncRNA-based therapeutic modalities that have been developed include miRNA mimics, antagomirs, and target protectors. Each of these has its own limitations and challenges that have to be overcome as well as its own delivery system, but all hold promise in cancer therapy. There is substantial expectations for clinical application of these promising technologies in the near future.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
